[Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G, Máthé C, Müller V, Szondy K, Moldvay J.
Losonczy G, et al. Among authors: moldvay j.
Magy Onkol. 2010 Dec;54(4):289-96. doi: 10.1556/MOnkol.54.2010.4.3.
Magy Onkol. 2010.
PMID: 21163759
Free article.
Hungarian.
Moreover, decreased renal function will not limit the full dose administration of several other cytotoxic agents. Losonczy G, Mathe C, Muller V, Szondy K, Moldvay J. Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung can …
Moreover, decreased renal function will not limit the full dose administration of several other cytotoxic agents. Losonczy G, Mathe C, Mulle …